Edoardo Biondi

Successful Treatment of a Patient with a Thymoma and Pure Red-Cell Aplasia with Octreotide and Prednisone

Giovannella Palmieri, Secondo Lastoria, Annamaria Colao et al. · New England Journal of Medicine · 1997 · 101 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

Sabino De Placido, Ciro Gallo, Michelino De Laurentiis et al. · The Lancet Oncology · 2018 · 88 citations · Full text

Medicine, Endocrinology, Oncology +11

Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients

Annamaria Ruzzo, Francesco Graziano, Fabio Galli et al. · British Journal of Cancer · 2017 · 68 citations · Full text

Medicine, Oncology, Pharmacology +17

Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients

Annamaria Ruzzo, Francesco Graziano, Fabio Galli et al. · Scientific Reports · 2014 · 42 citations · Full text

Medicine, Oncology, Pharmacology +17

Sociodemographic factors associated with the diagnostic staging of breast cancer in Southern Italy

Maurizio Montella, Edoardo Biondi, Mariarosaria De Marco et al. · Cancer · 1995 · 30 citations

Medicine, Demography, Oncology +13